Immune to Cancer: The CRI Blog
-
Sarcoma Awareness Month: 2021 Immunotherapy Research Updates
This July for Sarcoma Awareness Month, we look at new research, new treatments, and how we’re working…
-
Sarcoma Awareness Month: Tackling Chordoma with Dr. Cassian Yee
CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with…
-
Ask Miguel Anything: CRI Fellow Dr. Miguel Reina-Campos Answers Reddit User Questions About Cancer Metabolism and the Immune System
CRI Fellow Dr. Miguel Reina-Campos answers Reddit users’ questions about cancer metabolism and the immune system.
-
CRI Fellow Dr. Kamir Hiam-Galvez Shares a Day in His Life on CRI’s Twitter
Get to know Dr. Kamir Hiam-Galvez: immunologist, coffee drinker, music lover, and CRI Irvington Postdoctoral Fellow at…
-
Acute Lymphoblastic Leukemia Survivor Kristin Kleinhofer Takes Over CRI’s Instagram
Patient advocate and leukemia survivor Kristin shares a day in her life on Instagram.
-
ASCO21 Recap: Immunotherapy’s Continued Progress and Addressing Healthcare Disparities
ASCO21 highlighted the latest immunotherapy advances in checkpoint inhibition and cell therapies, and addressed disparities in healthcare.
-
Cell Therapy Development Lagged in 2020 But Is Gaining Ground Again, New CRI Report Shows
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
-
COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis
A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…
-
Impacto de la pandemia de COVID-19 en los ensayos clínicos oncológicos: análisis de seguimiento a un año
Un nuevo informe del CRI destaca la repercusión de la pandemia de COVID-19 en los ensayos clínicos…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.